Quantitation of 5HT(2A) receptor mRNA in human postmortem brain using competitive RT-PCR

NeuroReport

Volumn 9, Issue 17, 1998, Pages 3761-3765

  Dwivedi, Yogesh ^a   Pandey, Ghanshyam N ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

5HT(2A) receptor mRNA; Competitive RT PCR; Human postmortem brain

Indexed keywords

MESSENGER RNA; SEROTONIN 2A RECEPTOR; PRIMER DNA; SEROTONIN RECEPTOR;

AMYGDALOID NUCLEUS; ARTICLE; AUTOPSY; BRAIN; BRAIN CORTEX; CADAVER; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; MENTAL DISEASE; NEUROPSYCHIATRY; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION; BINDING COMPETITION; BRAIN MAPPING; GENETICS; METABOLISM; PATHOLOGY; SENSITIVITY AND SPECIFICITY; STANDARD;

BINDING, COMPETITIVE; BRAIN; BRAIN MAPPING; DNA PRIMERS; HUMANS; RECEPTORS, SEROTONIN; REFERENCE STANDARDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 0032217042     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199812010-00001     Document Type: Article

References (22)

1. Jacobs BL and Formal CA. Serotonin and behaviour: a general hypothesis. In: Bloom FE and Meltzer HY, eds. Psychopharmacology: the Fourth Generation of Progress. New York: Raven Press, 1995: 461-469.
2. Lucki I and Wieland S. Neuropsychopharmacology 3, 481-493 (1988).
3. Hoyer D, Clarke DE, Fozard JR et al. Pharmacol Rev 46, 157-203 (1994).
4. Baxter G, Kennet G, Blaney F et al. Trends Pharmacol Sci 16, 105-110 (1995).
5. Pandey GN, Pandey SC, Dwivedi Y et al. Am J Psychiatry 152, 850-855 (1995).
6. Cheetham SC, Crompton MR, Katona CLE et al. Psychopharmacology 102, 544-548 (1990).
7. Laruelle M, Abi-Dargham A, Casanova MF et al. Arch Gen Psychiatry 5, 810-818 (1993).
8. Arango V, Ernsberger P, Marzuk PM et al. Arch Gen Psychiatry 47, 1038-1047 (1990).
9. Hrdina PD, Demeter E, Vu TB et al. Brain Res 614, 37-44 (1993).
10. Cross AJ, Crow TJ, Ferrier IN et al. J Neurochem 43, 1574-81 (1984).
11. Zifa E and Fillion G. Pharmacol Rev 44, 408-481 (1992).
12. Boess FG and Martin IL. Neuropharmacology 33, 275-313 (1990).
13. Pazos A, Probst A and Palacios JM. Neuroscience 21, 123-139 (1987).
14. Wright DE, Seroogy KB, Lundgren KH et al. J Comp Neurol 351, 357-373 (1995).
15. Buckland P, D'Souza U, Maher NA et al. Brain Res Mol Res 48, 45-52 (1997).
16. Burnet PWJ, Eastwood SL and Harrison PJ. Neurosci Lett 178, 85-89 (1994).
17. Burnet PWJ, Eastwood SL, Lacey K et al. Brain Res 676, 157-168 (1995).
18. Pasqualetti M, Nardi I, Ladinsky H et al. Brain Res Mol Brain Res 39, 223-233 (1996).
19. Chirgwin JM, Przybyla AE, MacDonald RJ et al. Biochemistry 18, 5294-5299 (1979).
20. Chen K, Yang W, Grimsby J et al. Brain Res Mol Brain Res 14, 20-26 (1992).
21. Ho SN, Hunt HD, Horton RM et al. Gene 77, 51-59 (1989).
22. Sambrook J, Fritsch EF and Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd edn. New York: Cold Spring Harbor Laboratory, 1989.